Streetbeat News

Revenues

GIC

Global Industrial (NYSE:GIC) reported Q4 2023 earnings of $0.400 per share, meeting analyst estimates, with sales of $320.100M, exceeding expectations by 2.11% and marking a 22.88% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 9:51 pm

BLFS

BioLife Solutions projects its 2024 revenue to be between $95.5 million and $100 million, excluding income from its freezer business. This forecast provides insight into the company's financial health and strategic focus away from its freezer segment.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 9:44 pm

XPOF

Xponential Fitness projects its FY24 revenue to be between $340M-$350M, which is around the analyst estimate of $346.18M.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 9:43 pm

FIHL

Fidelis Insurance Holdings (FIHL) reported Q4 2023 adjusted EPS of $1.150, surpassing the $0.790 estimate, marking a 45.57% beat and a 76.92% increase YoY. Sales reached $553.7M, up 29.10% from $428.9M YoY.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 9:43 pm

PBYI

Puma Biotechnology projects its FY24 net product revenue to be between $183M and $190M.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 9:43 pm

PBYI

Puma Biotechnology projects its Q1 2024 net product revenue to be between $38M and $40M.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 9:42 pm

BFS

Saul Centers (NYSE:BFS) reported a 9.72% increase in quarterly earnings per share, rising from $0.72 to $0.79 YoY. Sales also increased by 6.97% to $66.68M from $62.34M YoY.

Portfolio Pulse from Happy Mohamed

February 29, 2024 | 9:40 pm

AVPT

AvePoint forecasts Q1 total revenues to be between $71.4M and $73.4M, surpassing the estimated $70.07M. For FY24, the company expects revenues to range from $308.6M to $316.6M, which brackets the $312.3M estimate.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 9:40 pm

PTCT

PTC Therapeutics projects its FY24 revenue to be in the range of $600M-$680M, compared to the estimated $612.290M by analysts.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 9:40 pm

EVLV

Evolv Technologies projects its FY24 revenue to be approximately $115 million, slightly above the estimated $114 million.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 9:39 pm